Market Chameleon (Thu, 4-Jun 4:19 AM ET)
Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
Globe Newswire (Wed, 3-Jun 4:01 PM ET)
Top Executive Makes Bold Insider Move at Alignment Healthcare
TipRanks (Tue, 2-Jun 10:14 PM ET)
Globe Newswire (Tue, 2-Jun 8:00 AM ET)
Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Globe Newswire (Mon, 18-May 8:00 AM ET)
Globe Newswire (Thu, 14-May 4:01 PM ET)
Globe Newswire (Tue, 12-May 4:30 PM ET)
Alignment Healthcare Set to Join S&P SmallCap 600
PRNewswire (Mon, 11-May 6:22 PM ET)
Globe Newswire (Thu, 30-Apr 4:01 PM ET)
Globe Newswire (Thu, 9-Apr 8:00 AM ET)
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Alignment Healthcare trades on the NASDAQ stock market under the symbol ALHC.
As of June 5, 2026, ALHC stock price climbed to $15.37 with 3,685,773 million shares trading.
ALHC has a beta of 0.81, meaning it tends to be less sensitive to market movements. ALHC has a correlation of 0.05 to the broad based SPY ETF.
ALHC has a market cap of $3.18 billion. This is considered a Mid Cap stock.
Last quarter Alignment Healthcare reported $1 billion in Revenue and $.05 earnings per share. This beat revenue expectation by $17 million and missed earnings estimates by -$.02.
In the last 3 years, ALHC traded as high as $23.87 and as low as $4.46.
The top ETF exchange traded funds that ALHC belongs to (by Net Assets): VTI, VB, IWM, IJR, VBK.
ALHC has underperformed the market in the last year with a price return of +0.3% while the SPY ETF gained +25.0%. ALHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -18.6% and -6.1%, respectively, while the SPY returned +7.9% and -0.7%, respectively.
ALHC support price is $14.49 and resistance is $15.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALHC shares will trade within this expected range on the day.